T1	Participants 41 95	patients receiving hemodialysis or peritoneal dialysis
T2	Participants 184 240	groups reporting hypermagnesemia and some hypomagnesemia
T3	Participants 514 545	66 age matched control subjects
T4	Participants 682 712	hemodialysis and CAPD patients
T5	Participants 985 996	three group
T6	Participants 1263 1293	hemodialysis and CAPD patients
T7	Participants 1350 1366	control subjects
